SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-051141
Filing Date
2023-10-02
Accepted
2023-10-02 16:24:12
Documents
15
Period of Report
2023-09-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K revb-20230927.htm   iXBRL 8-K 61239
2 EX-99.1 revb-ex99_1.htm EX-99.1 20988
3 GRAPHIC img220778470_0.jpg GRAPHIC 18521
  Complete submission text file 0000950170-23-051141.txt   275788

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT revb-20230927_def.xml EX-101.DEF 14413
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT revb-20230927_lab.xml EX-101.LAB 19062
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT revb-20230927_pre.xml EX-101.PRE 13721
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT revb-20230927.xsd EX-101.SCH 3514
9 EXTRACTED XBRL INSTANCE DOCUMENT revb-20230927_htm.xml XML 6958
Mailing Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122
Business Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122 650-800-3717
REVELATION BIOSCIENCES, INC. (Filer) CIK: 0001810560 (see all company filings)

IRS No.: 843898466 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39603 | Film No.: 231300007
SIC: 2834 Pharmaceutical Preparations